Back
Open Access

Welcome and introduction.

Session: A new era for HFpEF – Exploring the role of empagliflozin in practice
Topic: Chronic Heart Failure
Speaker: Professor A. Coats (Coventry, GB)
Sponsored by Boehringer Ingelheim and Eli Lilly and Company
Event: Heart Failure 2022

Congress Presentation

About the speaker

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
109 presentations
19 followers

3 more presentations in this session

What is the evidence for empagliflozin in HF?

Speaker: Professor J. Butler (Dallas, US)

Access
Slides
Video
Thumbnail

Using empagliflozin for HFpEF treatment - what does this look like in practice?

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Access
Slides
Video
Thumbnail

Panel discussion and close.

Speaker: Professor A. Coats (Coventry, GB)

Access
Slides
Video
Thumbnail

Access the full session

A new era for HFpEF – Exploring the role of empagliflozin in practice

Speakers: Professor A. Coats, Professor J. Butler, Doctor S. Zieroth, Professor A. Coats
Access
Video
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb